What are the requirements for sequence disclosures in biotechnology patent applications?
MPEP 2401 introduces the requirements for sequence disclosures in biotechnology patent applications. These requirements are outlined in 37 CFR 1.821 – 1.825 and 37 CFR 1.831 – 1.835. The regulations cover:
- Nucleotide sequence disclosures
- Amino acid sequence disclosures
- Format and symbols to be used
- Sequence listing requirements
- Electronic submission procedures
These rules ensure that sequence information is presented in a standardized, searchable format, facilitating examination and public access to the genetic information claimed in patents.
To learn more:
Topics:
MPEP 2400 - Biotechnology,
MPEP 2401 - Introduction,
Patent Law,
Patent Procedure